Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 9 | $15,724,108 |
| Sells | 9 | $264,202 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 12 Sep 2024 17:19 | JSPR | Jasper Therapeutics Inc | MAHAL JEETINDER SINGH | Chief Operating Officer | 12 Sep 2024 | Sale | 900 | 21.2263 | 19,104 | D |
| 12 Jun 2024 21:40 | JSPR | Jasper Therapeutics Inc | MAHAL JEETINDER SINGH | Chief Operating Officer | 12 Jun 2024 | Sale | 900 | 24.155 | 21,740 | D |
| 12 Mar 2024 21:33 | JSPR | Jasper Therapeutics Inc | MAHAL JEETINDER SINGH | Chief Operating Officer | 12 Mar 2024 | Sale | 900 | 26.4358 | 23,792 | D |
| 12 Feb 2024 18:23 | JSPR | Jasper Therapeutics Inc | CARLYLE GROUP INC. | Former 10% Owner | 08 Feb 2024 | Purchase | 190,000 | 12.95 | 2,460,500 | I |
| 09 Feb 2024 20:40 | JSPR | Jasper Therapeutics Inc | VELAN CAPITAL INVESTMENT MANAGEMENT LP | 10% | 08 Feb 2024 | Purchase | 350,000 | 12.95 | 4,532,500 | I |
| 30 Nov 2023 16:05 | JSPR | Jasper Therapeutics Inc | WIGGANS THOMAS G | Director | 28 Nov 2023 | Purchase | 10,000 | 0.6486 | 6,486 | D |
| 22 Nov 2023 16:06 | JSPR | Jasper Therapeutics Inc | WIGGANS THOMAS G | Director | 21 Nov 2023 | Purchase | 10,000 | 0.6383 | 6,383 | D |
| 20 Nov 2023 20:14 | JSPR | Jasper Therapeutics Inc | WIGGANS THOMAS G | Director | 20 Nov 2023 | Purchase | 10,000 | 0.6309 | 6,309 | D |
| 20 Nov 2023 20:14 | JSPR | Jasper Therapeutics Inc | WIGGANS THOMAS G | Director | 17 Nov 2023 | Purchase | 10,000 | 0.5966 | 5,966 | D |
| 20 Nov 2023 20:14 | JSPR | Jasper Therapeutics Inc | WIGGANS THOMAS G | Director | 16 Nov 2023 | Purchase | 10,000 | 0.5965 | 5,965 | D |
| 13 Oct 2023 18:56 | JSPR | Jasper Therapeutics Inc | LIS WILLIAM | Director | 13 Oct 2023 | Sale | 7,965 | 0.8508 | 6,777 | D |
| 13 Jun 2023 20:54 | JSPR | Jasper Therapeutics Inc | MAHAL JEETINDER SINGH | See Remarks | 13 Jun 2023 | Sale | 9,000 | 1.6572 | 14,915 | D |
| 14 Apr 2023 16:19 | JSPR | Jasper Therapeutics Inc | FRENCH ANNA LOUISE | Director | 14 Apr 2023 | Sale | 7,000 | 1.48 | 10,360 | D |
| 14 Apr 2023 16:19 | JSPR | Jasper Therapeutics Inc | EMSTER KURT VON | Director | 13 Apr 2023 | Sale | 9,075 | 1.4903 | 13,524 | D |
| 14 Apr 2023 16:14 | JSPR | Jasper Therapeutics Inc | LIS WILLIAM | Director | 13 Apr 2023 | Sale | 8,500 | 1.44 | 12,240 | D |
| 11 Apr 2023 19:55 | JSPR | Jasper Therapeutics Inc | QIMING U.S. HEALTHCARE FUND II, L.P. | 10% | 27 Jan 2023 | Purchase | 2,666,666 | 1.5 | 3,999,999 | D |
| 31 Jan 2023 17:24 | JSPR | Jasper Therapeutics Inc | CARLYLE GROUP INC. | 10% | 27 Jan 2023 | Purchase | 3,133,333 | 1.5 | 4,700,000 | I |
| 26 Jan 2023 17:49 | JSPR | Jasper Therapeutics Inc | ROCHE HOLDING LTD | 10% | 25 Jan 2023 | Sale | 75,000 | 1.89 | 141,750 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)